Volume 4, Issue 8, Pages 627-633 (August 2017) Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis Tabea Schoeler, PhD, Natalia Petros, MSc, Marta Di Forti, PhD, Ewa Klamerus, BSc, Enrico Foglia, BSc, Robin Murray, FRS, Dr Sagnik Bhattacharyya, PhD The Lancet Psychiatry Volume 4, Issue 8, Pages 627-633 (August 2017) DOI: 10.1016/S2215-0366(17)30233-X Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure Path model—medication adherence as a mediator of the association between continued cannabis use and relapse Conceptualised pathways between continuation of cannabis use and risk of relapse, with the total effects transmitting both directly (solid line—C), and indirectly (dashed lines—A and B) via medication adherence. The Lancet Psychiatry 2017 4, 627-633DOI: (10.1016/S2215-0366(17)30233-X) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions